|
Combinative technology | Pretreatment | Particle size reduction technique | Drug | Smallest reported mean particle size | Length of the nanosuspension production | Administration focus | Reference |
|
NANOEDGE | Microprecipitation | HPH | Paclitaxel | 200 nm | 20000 psi for 30 min (Avestin C50) | I.V. (reformulation as nanosuspension to eliminate cremophor EL as excipient) | [27] |
NANOEDGE | Microprecipitation | HPH | Nabumetone | 930 nm | 20000 psi for 30 min (Avestin C50) | I.V. | [25] |
NANOEDGE | Microprecipitation | HPH | Prednisolone | 640 nm | 10000 psi for 15 min (Avestin C50) | I.V. | [25] |
NANOEDGE | Microprecipitation | HPH | Carbamazepin | 400 nm | 20000 psi for 15 min (Avestin C50) | I.V. | [25] |
NANOEDGE | Microprecipitation | HPH | Itraconazol | 581 nm | 20000 psi for 30 min (Avestin C50) | I.V. | [29] |
NANOEDGE | Microprecipitation | Sonication | Itraconazol | 177 nm | 1 min 10000 Hz (400 W) | I.V. | [25] |
“Nanoedge-like” | Microprecipitation | HPH | Meloxicam | 212 nm | 15 cycles 500 bar (ATS AH110D) | Oral | [32] |
“Nanoedge-like” | Microprecipitation | HPH | Isradipine | 469 nm | 30 cycles 1200 bar (GEA Niro Soavi) | Oral | [31] |
“Nanoedge-like” | Microprecipitation | HPH | 10-hydroxycamptothecin (10-HCPT) | 131 nm | 20 cycles 1000 bar (ATS AH110D) | Oral | [30] |
“Nanoedge-like” | Microprecipitation | Sonication | Hydrocortisone | 80 nm | 5 min | Oral | [36] |
“Nanoedge-like” | Microprecipitation | Sonication | Ibuprofen | 702 nm | 60 min | Oral | [4] |
“Nanoedge-like” | Microprecipitation | Sonication | Nitrendipine | 209 nm | 15 min 20000 Hz (400 W) | Oral | [33] |
“Nanoedge-like” | Microprecipitation | Sonication | All-trans retinoic acid | 155 nm | 30 min | Oral | [34] |
“Nanoedge-like” | Microprecipitation | Sonication | Meloxicam | 259 nm | 20 min (300 W) | Oral | [32] |
|
H 69 | Cavi-precipitation | HPH | Ibuprofen | 170 nm | 10 cycles 1200 bar (Avestin C5) | Oral | [38] |
H 69 | Cavi-precipitation | HPH | Hydrocortisone acetate (HCA) | 787 nm | 20 cycles 1500 bar (Micron LAB 40) | Oral | [37] |
H 69 | Cavi-precipitation | HPH | Resveratrol | 150 nm | 10 cycles 1200 bar (Avestin C5) | Oral | [38] |
H 69 | Cavi-precipitation | HPH | Omeprazol | 921 nm | 20 cycles 1500 bar (Micron LAB 40) | Oral | [37] |
H 69 | Cavi-precipitation | HPH | Prednisolone | 22 nm | 1500 bar for 6 min (Micron LAB 40) | Oral | [37] |
|
H 42 | Spray-drying | HPH | Amphotericin B | 172 nm | 20 cycles 1500 bar (Micron LAB 40) | Oral | [39] |
H 42 | Spray-drying | HPH | Glibenclamide | 236 nm | 20 cycles 1500 bar (Micron LAB 40) | Oral | [3] |
H 42 | Spray-drying | HPH | Hydrocortisone acetate (HCA) | 281 nm | 20 cycles 1500 bar (Micron LAB 40) | Oral | [2] |
H 42 | Spray-drying | HPH | Ibuprofen | 636 nm | 20 cycles 1500 bar (Micron LAB 40) | Oral | [39] |
H 42 | Spray-drying | HPH | Resveratrol | 200 nm | 1 cycle 1500 bar (Micron LAB 40) | Oral | [40] |
|
H 96 | Freeze-drying | HPH | Amphotericin B | 62 nm | 5 cycles 1500 bar (Micron LAB 40) | Oral | [41] |
H 96 | Freeze-drying | HPH | Glibenclamide | 164 nm | 20 cycles 1500 bar (Micron LAB 40) | Oral | [44] |
H 96 | Freeze-drying | HPH | Cyclosporin A | 440 nm | 15 cycles 1500 bar (Micron LAB 40) | Oral | [41] |
H 96 | Freeze-drying | HPH | Hydrocortisone acetate (HCA) | 414 nm | 10 cycles 1500 bar (Micron LAB 40) | Oral | [41] |
|
CT | Pearl milling | HPH | Rutin | 604 nm | 1 cycle 100 bar (Avestin C50) | Topical/oral | [6] |
CT | Pearl milling | HPH | Hesperidin | 599 nm | 5 cycles 1000 bar (Micron LAB 40) | Topical/oral | [6] |
CT | Pearl milling | HPH | Apigenin | 275 nm | 1 cycle 300 bar (Avestin C50) | Topical/oral | [6] |
|